Pratik Devasthale
34Patents
8h-index
55Co-inventors
78Inventor score
Filing activity: Mar 20, 2001 → May 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6414002B1 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 72 | Expired |
| US6673815B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Human Necessities | 59 | Expired |
| US6727271B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 45 | Expired |
| US6653314B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 22 | Expired |
| US8580959B2 | Azolotriazinone melanin concentrating hormone receptor-1 antagonists | Human Necessities | 18 | Active |
| US8791091B2 | Aryl dihydropyridinone and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 18 | Active |
| US9187424B1 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 10 | Active |
| US7279485B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 9 | Expired |
| US9663466B2 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US7053106B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 8 | Expired |
| US9901572B2 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US6919358B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 6 | Expired |
| US7521557B2 | Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods | Human Necessities | 5 | Expired |
| US8415386B2 | Azolopyrrolone melanin concentrating hormone receptor-1 antagonists | Human Necessities | 3 | Active |
| US7989433B2 | Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists | Human Necessities | 3 | Active |
| US7557143B2 | Thyroid receptor ligands | Chemistry; Metallurgy | 3 | Expired |
| US10369140B2 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7084162B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 2 | Expired |
| US10968219B2 | 3-substituted propionic acids as αV integrin inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10695328B2 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7951793B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 1 | Active |
| US7241780B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | Chemistry; Metallurgy | 1 | Expired |
| US9974778B2 | Substituted pyridinones as MGAT2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10851098B2 | Azole amides and amines as alpha v integrin inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11639353B2 | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.